Skip to main contentAI and Advanced
/
PHARMABEES · NSEBSE SENSEX78,499.17-0.58%BSE |
NIFTY 5024,570.65-0.27%NSE |
NIFTY BANK57,746.45-0.55%NSE |
NIFTY IT31,547.7+1.42%NSE |
NIFTY AUTO29,647.9+1.84%NSE |
NIFTY FMCG49,435.2+0.13%NSE |
NIFTY PHARMA26,541.8-0.09%NSE |
NIFTY 50023,712.1-0.07%NSE |
PH
NSE · Funds & ETFs · Not available0.03 · 0.11%
NIPPONAMC - NETFPHARMA PHARMABEES
NSE:INR 27.32
BSE:INR 27.31
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsData unavailable
Research sections2 of 9 availableMissing source values remain unavailable, never zero-filled.
This listed security has price history but no canonical company-fundamentals document. Financials, valuation, ownership and company-profile gaps are source coverage gaps, not zero values.
AI analysis and Advanced tools for PHARMABEES
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
OpenINR 27.5
Previous closeINR 27.29
Day rangeINR 27.18 — INR 27.5
52-week rangeINR 21.46 — INR 27.95
Volume30.06 L
Market capNot available
P/ENot available
IndustryNot available
ISININF204KC1089
Research path: Interpret NIPPONAMC - NETFPHARMA's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
PHARMABEESNIPPONAMC - NETFPHARMA1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated in the browser from validated historical candles. This is descriptive research, not a buy or sell recommendation.
Calculating technicals…
Company reporting
Financial statements
BSE reported results · INR crore
Financial statement rows are unavailable.
Fundamentals
Valuation and ratios
Valuation data unavailable.
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
Ownership data is not present in the normalized source.
Corporate actions
Events
Corporate event data unavailable.
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Relevant company news is unavailable.
ShareKeyX Community
Discussion and sentiment for NIPPONAMC - NETFPHARMA
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
Not available
- Industry
- Not available
- Sector
- Not available
- Website
- Not available
- Address
- Not available
- NSE Code
- PHARMABEES
- BSE Code
- 590142
Questions
Stock FAQ
What is the symbol and ISIN of NIPPONAMC - NETFPHARMA?
NIPPONAMC - NETFPHARMA has the symbol PHARMABEES and ISIN - INF204KC1089.
What is the current price of NIPPONAMC - NETFPHARMA?
NIPPONAMC - NETFPHARMA is currently trading at INR 27.32.
What are the year high and year low of NIPPONAMC - NETFPHARMA?
NIPPONAMC - NETFPHARMA has a year high of INR 27.95 and a year low of INR 21.46.
What is the market capitalization of NIPPONAMC - NETFPHARMA?
NIPPONAMC - NETFPHARMA has a market capitalization of NA.
What is the P/E ratio of NIPPONAMC - NETFPHARMA?
NIPPONAMC - NETFPHARMA has a P/E ratio of NA.
What is the dividend yield of NIPPONAMC - NETFPHARMA?
NIPPONAMC - NETFPHARMA has a dividend yield of NA.
How is the financial performance of NIPPONAMC - NETFPHARMA based on revenue, net income, and EPS?
NIPPONAMC - NETFPHARMA has revenue of NA, net income of NA, and EPS of NA.
What is the book value of NIPPONAMC - NETFPHARMA?
NIPPONAMC - NETFPHARMA has a book value of NA.
What is the debt-to-equity ratio of NIPPONAMC - NETFPHARMA?
NIPPONAMC - NETFPHARMA has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of NIPPONAMC - NETFPHARMA?
NIPPONAMC - NETFPHARMA has a price-to-book ratio of NA and a price-to-sales ratio of NA.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.